The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1958, 80: 299-307.
Copyright © 1958 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hilleman, M. R.
Right arrow Articles by Levinson, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hilleman, M. R.
Right arrow Articles by Levinson, D. J.

Antibody Response in Volunteers to Adenovirus Vaccine and Correlation of Antibody with Immunity

M. R. Hilleman, F. J. Flatley, S. A. Anderson, M. L. Luecking and D. J. Levinson

From the Department of Respiratory Diseases, Walter Reed Army Institute of Research, Washington, D. C.

Abstract

Formalin-killed bivalent and monovalent types 4 and 7 adenovirus vaccines prepared under commercial conditions were assayed for homologous and heterologous neutralizing antibody response in a study with 267 volunteers. The vaccine employed in the studies induced a neutralizing antibody titer of 1:1 in guinea pigs against type 4 virus and 1:4 against type 7 virus when assayed by the standard test method employed. Dilution of bivalent vaccine more than 1:2 for type 4 component and around 1:27 for type 7 component significantly reduced the antibody response to the vaccine. The type 7 component induced a high level of neutralizing antibody against types 7, 7a, and 3 with essentially no antibody against types 4 or 14, and the type 4 component induced significant antibody against type 4 virus only. Bivalent vaccine given in 1 ml amount by jet gun or in 0.1 ml volume intradermally induced as much antibody as the 1 ml dose given intramuscularly. The antibody stimulated against bivalent vaccine was reduced by no more than 50% during a 10 month period post-vaccination and the response to a booster dose of vaccine given at that time elevated the titer only slightly above that achieved initially. There was a close correlation between the occurrence of serum neutralizing antibody and failure to develop adenovirus-caused respiratory illness among recruits in basic training. The level of antibody associated with immunity appeared in most cases not to exceed a titer of 1:1 when assayed by the standard method employed in this laboratory. The occurrence of type 3 antibody in persons whose sera were devoid of type 7 antibody, appeared to afford some protection against type 7 virus disease though this was not always the case. The significance of the finding in relation to the application and use of adenovirus vaccine is discussed.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1958 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1958 by The American Association of Immunologists, Inc. All rights reserved.